Form 8-K Horizon Pharma plc For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Horizon Pharma (HZNP) Tops Q4 EPS by 5c; Boosts FY15 Outlook
February 27, 2015 7:12 AM ESTHorizon Pharma (NASDAQ: HZNP) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $95.5 million.
2015 Guidance
The Company today announced it is raising 2015 full year guidance as follows:
Prior Guidance New Guidance
--------------------... More



